Alternatives to Animal Testing

4
Sep

PRESS RELEASE – Genoskin launches new offering: NativeSkin access

Genoskin, a biotechnology company developing ready-to-use human skin biopsies for ex vivo clinical testing, announces today the launch of its newest offering, NativeSkin® access, a ready-to-use standardized skin model.

4
Mar

Top differences between human and animal skin

Top differences between human and animal skin Are animal models used in skin research? Animal models have been widely used in skin research. They are often used to study percutaneous absorption, wound healing, skin inflammation and psoriasis. These studies require relevant models in terms of structure and immunology to assess human skin response and to de-risk clinical trials on humans. The
Read more
18
Sep

PRESS RELEASE – Genemarkers and Genoskin announce new partnership

Genemarkers and Genoskin are pleased to announce they have formed a partnership to provide exceptional value and service to researchers in the fields of cosmetic and pharmaceutical topical solutions. The Companies are currently performing collaborative work to understand how cannabidiol (CBD) acts in the skin.

22
Feb

Ex vivo human skin models for cosmetic testing

Standardized ex vivo skin models for cosmetic testing Cosmetic testing is playing an increasingly important role in today’s cosmetic industry. The first cosmetic tests took place in 1933, after an eyelash darkening treatment blinded several women. In 1938, the U. S. Food and Drug Administration passed the Federal Food, Drug & Cosmetic (FD&C) Act to define stricter regulations for cosmetic products
Read more
15
Feb

Genoskin develops new perfusable vascularized skin model

New ex vivo perfusable vascularized human skin model for drug testing Perfusable vascularized skin for increased viability and optimal skin response Natural human skin contains a rich vascular network, which is essential for the transport and absorption of nutrients and drugs. However, a key drawback of currently engineered human skin models is their lack in vascularization. Recreating a vascularization in
Read more
29
Sep

Genoskin launches psoriasis skin model at ESDR-meeting

Toulouse, France, September 29th, 2017 – Genoskin launches a new skin model to study skin inflammation. InflammaSkin® is a T cell-driven skin inflammation model with a psoriasis-like phenotype. The pharmacological validation of this psoriasis skin model will be presented at the 47th annual ESDR meeting 2017 (Poster 100) on September 27th to 30th, 2017. Don't hesitate to visit us in booth #9. Why immunocompetent skin
Read more